Oscar Health Target of Unusually Large Options Trading (NYSE:OSCR)

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) was the target of unusually large options trading on Friday. Stock investors purchased 9,804 call options on the stock. This represents an increase of 166% compared to the typical volume of 3,680 call options.

Insider Transactions at Oscar Health

In related news, CAO Victoria Baltrus sold 4,226 shares of the business's stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $76,025.74. Following the sale, the chief accounting officer now owns 140,648 shares of the company's stock, valued at $2,530,257.52. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Alessandrea C. Quane sold 16,793 shares of Oscar Health stock in a transaction on Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $286,488.58. Following the completion of the sale, the executive vice president now owns 392,607 shares of the company's stock, valued at approximately $6,697,875.42. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Victoria Baltrus sold 4,226 shares of the company's stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $76,025.74. Following the sale, the chief accounting officer now directly owns 140,648 shares of the company's stock, valued at $2,530,257.52. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 169,569 shares of company stock worth $3,007,069. Company insiders own 25.11% of the company's stock.

Hedge Funds Weigh In On Oscar Health

Several large investors have recently modified their holdings of the stock. Wealth Enhancement Advisory Services LLC grew its stake in shares of Oscar Health by 7.5% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company's stock valued at $255,000 after acquiring an additional 844 shares in the last quarter. American International Group Inc. grew its holdings in shares of Oscar Health by 1.3% during the 1st quarter. American International Group Inc. now owns 79,411 shares of the company's stock worth $1,181,000 after purchasing an additional 1,009 shares in the last quarter. Summit Trail Advisors LLC increased its position in shares of Oscar Health by 5.4% in the second quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company's stock worth $329,000 after purchasing an additional 1,065 shares during the period. Arizona State Retirement System raised its stake in Oscar Health by 3.7% in the second quarter. Arizona State Retirement System now owns 38,059 shares of the company's stock valued at $602,000 after purchasing an additional 1,351 shares in the last quarter. Finally, Amalgamated Bank lifted its position in Oscar Health by 27.7% during the second quarter. Amalgamated Bank now owns 6,727 shares of the company's stock worth $106,000 after purchasing an additional 1,458 shares during the period. 75.70% of the stock is owned by institutional investors.

Oscar Health Stock Performance

Shares of Oscar Health stock traded up $0.85 during trading on Friday, hitting $17.65. 3,847,408 shares of the stock were exchanged, compared to its average volume of 3,208,975. Oscar Health has a 1-year low of $5.30 and a 1-year high of $23.79. The stock has a market capitalization of $4.27 billion, a price-to-earnings ratio of -132.76, a price-to-earnings-growth ratio of 33.76 and a beta of 1.62. The company has a fifty day moving average price of $18.74 and a 200-day moving average price of $18.36. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The company had revenue of $2.20 billion during the quarter, compared to analysts' expectations of $2.13 billion. During the same period last year, the firm posted ($0.07) earnings per share. The business's revenue was up 44.6% on a year-over-year basis. As a group, equities analysts predict that Oscar Health will post 0.01 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts have issued reports on OSCR shares. UBS Group started coverage on shares of Oscar Health in a research report on Monday, October 7th. They issued a "neutral" rating and a $23.00 price target on the stock. Piper Sandler reaffirmed an "overweight" rating and set a $28.00 price objective on shares of Oscar Health in a report on Tuesday, September 10th. Three analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $24.00.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.